Survival Analysis of Glioblastoma: A Scientometric Perspective.

IF 1.9 4区医学 Q3 CLINICAL NEUROLOGY

World neurosurgery Pub Date : 2024-12-06 DOI:10.1016/j.wneu.2024.11.059

Zahra Alirezaei, Alireza Amouheidari, Reza BasirianJahromi, Shohreh Seyyedhosseini, Ali Hamidi

{"title":"Survival Analysis of Glioblastoma: A Scientometric Perspective.","authors":"Zahra Alirezaei, Alireza Amouheidari, Reza BasirianJahromi, Shohreh Seyyedhosseini, Ali Hamidi","doi":"10.1016/j.wneu.2024.11.059","DOIUrl":null,"url":null,"abstract":"Background: Glioblastoma is the most aggressive primary brain tumor and the outlook for patients is usually pessimistic. Numerous ongoing studies have focused on enhancing the survival rate of glioblastoma patients. This study aims to analyze the research trends surrounding glioblastoma survival and facilitate studying recent topics to provide insight into the perspective, research fields, and international collaborations.Methods: Data were collected from the Web of Science database documents published from 1980 to 2022 and analyzed using Citespace and Biblioshiny software. After analyzing the data, we visualized the co-occurrence and coauthorship networks.Results: Eighteen main clusters were formed by drawing a document cocitation network. The result indicates that prognostic biomarkers, treating field, T cell, radiomic feature, and 5-aminolevulinic acid were trending topics for researchers. The most active countries in this field are the United States, followed by China, Germany, and Italy, respectively.Conclusions: Considering the significance of monitoring the studies in glioblastoma patients, the current research has shown promising results in stratifying patient survival as a valuable tool for prognosis and prediction and eventually guiding treatment decisions. Using the results of this study, glioblastoma researchers can identify their potential colleagues and research gaps in this field.","PeriodicalId":23906,"journal":{"name":"World neurosurgery","volume":" ","pages":"123476"},"PeriodicalIF":1.9000,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.wneu.2024.11.059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Glioblastoma is the most aggressive primary brain tumor and the outlook for patients is usually pessimistic. Numerous ongoing studies have focused on enhancing the survival rate of glioblastoma patients. This study aims to analyze the research trends surrounding glioblastoma survival and facilitate studying recent topics to provide insight into the perspective, research fields, and international collaborations.

Methods: Data were collected from the Web of Science database documents published from 1980 to 2022 and analyzed using Citespace and Biblioshiny software. After analyzing the data, we visualized the co-occurrence and coauthorship networks.

Results: Eighteen main clusters were formed by drawing a document cocitation network. The result indicates that prognostic biomarkers, treating field, T cell, radiomic feature, and 5-aminolevulinic acid were trending topics for researchers. The most active countries in this field are the United States, followed by China, Germany, and Italy, respectively.

Conclusions: Considering the significance of monitoring the studies in glioblastoma patients, the current research has shown promising results in stratifying patient survival as a valuable tool for prognosis and prediction and eventually guiding treatment decisions. Using the results of this study, glioblastoma researchers can identify their potential colleagues and research gaps in this field.

查看原文本刊更多论文

胶质母细胞瘤的生存分析：科学计量学视角。

胶质母细胞瘤是侵袭性最强的原发性脑肿瘤，患者的前景通常比较悲观。许多正在进行的研究都侧重于提高胶质母细胞瘤患者的生存率。本研究旨在分析围绕胶质母细胞瘤存活率的研究趋势，并促进对最新课题的研究，从而提供对研究视角、研究领域和国际合作的见解。我们从科学网数据库中收集了1980年至2022年发表的文献数据，并使用Citespace和Biblioshiny软件进行了分析。分析数据后，我们将共现和共同作者网络可视化。.通过绘制文献共现网络，形成了18个主要聚类。结果表明，预后生物标志物、治疗领域、T细胞、放射学特征和5-氨基乙酰丙酸是研究人员关注的热门话题。该领域最活跃的国家是美国，其次分别是中国、德国和意大利。考虑到对胶质母细胞瘤患者进行监测研究的意义，目前的研究在对患者生存期进行分层方面取得了可喜的成果，成为预后和预测的重要工具，并最终指导治疗决策。利用这项研究的结果，胶质母细胞瘤研究人员可以找出这一领域的潜在同行和研究空白。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World neurosurgery CLINICAL NEUROLOGY-SURGERY

CiteScore

3.90

自引率

15.00%

发文量

1765

审稿时长

47 days

期刊介绍： World Neurosurgery has an open access mirror journal World Neurosurgery: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The journal''s mission is to: -To provide a first-class international forum and a 2-way conduit for dialogue that is relevant to neurosurgeons and providers who care for neurosurgery patients. The categories of the exchanged information include clinical and basic science, as well as global information that provide social, political, educational, economic, cultural or societal insights and knowledge that are of significance and relevance to worldwide neurosurgery patient care. -To act as a primary intellectual catalyst for the stimulation of creativity, the creation of new knowledge, and the enhancement of quality neurosurgical care worldwide. -To provide a forum for communication that enriches the lives of all neurosurgeons and their colleagues; and, in so doing, enriches the lives of their patients. Topics to be addressed in World Neurosurgery include: EDUCATION, ECONOMICS, RESEARCH, POLITICS, HISTORY, CULTURE, CLINICAL SCIENCE, LABORATORY SCIENCE, TECHNOLOGY, OPERATIVE TECHNIQUES, CLINICAL IMAGES, VIDEOS